139 related articles for article (PubMed ID: 9626765)
1. Cholyllysyl fluroscein and related lysyl fluorescein conjugated bile acid analogues.
Mills CO; Milkiewicz P; Saraswat V; Elias E
Yale J Biol Med; 1997; 70(4):447-57. PubMed ID: 9626765
[TBL] [Abstract][Full Text] [Related]
2. Different pathways of canalicular secretion of sulfated and non-sulfated fluorescent bile acids: a study in isolated hepatocyte couplets and TR- rats.
Mills CO; Milkiewicz P; Müller M; Roma MG; Havinga R; Coleman R; Kuipers F; Jansen PL; Elias E
J Hepatol; 1999 Oct; 31(4):678-84. PubMed ID: 10551392
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, physical and biological properties of lithocholyl-lysyl-fluorescein: a fluorescent monohydroxy bile salt analogue with cholestatic properties.
Mills CO; Milkiewicz P; Molloy DP; Baxter DJ; Elias E
Biochim Biophys Acta; 1997 Oct; 1336(3):485-96. PubMed ID: 9367176
[TBL] [Abstract][Full Text] [Related]
4. Transport characteristics of three fluorescent conjugated bile acid analogs in isolated rat hepatocytes and couplets.
Maglova LM; Jackson AM; Meng XJ; Carruth MW; Schteingart CD; Ton-Nu HT; Hofmann AF; Weinman SA
Hepatology; 1995 Aug; 22(2):637-47. PubMed ID: 7635434
[TBL] [Abstract][Full Text] [Related]
5. Visualization of the transport of primary and secondary bile acids across liver tissue in rats: in vivo study with fluorescent bile acids.
Milkiewicz P; Mills CO; Hubscher SG; Cardenas R; Cardenas T; Williams A; Elias E
J Hepatol; 2001 Jan; 34(1):4-10. PubMed ID: 11211906
[TBL] [Abstract][Full Text] [Related]
6. Hepatic transport mechanisms of cholyl-L-lysyl-fluorescein.
de Waart DR; Häusler S; Vlaming ML; Kunne C; Hänggi E; Gruss HJ; Oude Elferink RP; Stieger B
J Pharmacol Exp Ther; 2010 Jul; 334(1):78-86. PubMed ID: 20388726
[TBL] [Abstract][Full Text] [Related]
7. Cholyl-lysylfluorescein: synthesis, biliary excretion in vivo and during single-pass perfusion of isolated perfused rat liver.
Mills CO; Rahman K; Coleman R; Elias E
Biochim Biophys Acta; 1991 Dec; 1115(2):151-6. PubMed ID: 1764467
[TBL] [Abstract][Full Text] [Related]
8. Transport of fluorescent bile acids by the isolated perfused rat liver: kinetics, sequestration, and mobilization.
Holzinger F; Schteingart CD; Ton-Nu HT; Cerrè C; Steinbach JH; Yeh HZ; Hofmann AF
Hepatology; 1998 Aug; 28(2):510-20. PubMed ID: 9696018
[TBL] [Abstract][Full Text] [Related]
9. Fluorescent bile acid derivatives: relationship between chemical structure and hepatic and intestinal transport in the rat.
Holzinger F; Schteingart CD; Ton-Nu HT; Eming SA; Monte MJ; Hagey LR; Hofmann AF
Hepatology; 1997 Nov; 26(5):1263-71. PubMed ID: 9362371
[TBL] [Abstract][Full Text] [Related]
10. Lack of evidence for vesicle trafficking of fluorescent bile salts in rat hepatocyte couplets.
El-Seaidy AZ; Mills CO; Elias E; Crawford JM
Am J Physiol; 1997 Feb; 272(2 Pt 1):G298-309. PubMed ID: 9124354
[TBL] [Abstract][Full Text] [Related]
11. Quantification of Drug-Induced Inhibition of Canalicular Cholyl-l-Lysyl-Fluorescein Excretion From Hepatocytes by High Content Cell Imaging.
Barber JA; Stahl SH; Summers C; Barrett G; Park BK; Foster JR; Kenna JG
Toxicol Sci; 2015 Nov; 148(1):48-59. PubMed ID: 26220638
[TBL] [Abstract][Full Text] [Related]
12. Control by signaling modulators of the sorting of canalicular transporters in rat hepatocyte couplets: role of the cytoskeleton.
Roma MG; Milkiewicz P; Elias E; Coleman R
Hepatology; 2000 Dec; 32(6):1342-56. PubMed ID: 11093742
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and physicochemical, biological, and pharmacological properties of new bile acids amidated with cyclic amino acids.
Roda A; Cerrè C; Manetta AC; Cainelli G; Umani-Ronchi A; Panunzio M
J Med Chem; 1996 May; 39(11):2270-6. PubMed ID: 8667370
[TBL] [Abstract][Full Text] [Related]
14. The protein kinase inhibitor 1-(5-isoquinolinylsulfonyl)-2-methyl-piperzine (H-7) prevents and reverses Ca(2+)-mediated injury in isolated rat hepatocyte couplets.
Roma MG; Ahmed-Choudhury J; Coleman R
Toxicol Appl Pharmacol; 1999 Dec; 161(2):192-201. PubMed ID: 10581213
[TBL] [Abstract][Full Text] [Related]
15. Plasma elimination of cholyl-lysyl-fluorescein (CLF): a pilot study in patients with liver cirrhosis.
Milkiewicz P; Saksena S; Cardenas T; Mills CO; Elias E
Liver; 2000 Jul; 20(4):330-4. PubMed ID: 10959812
[TBL] [Abstract][Full Text] [Related]
16. Biliary lipid output by isolated perfused rat livers in response to cholyl-lysylfluorescein.
Baxter DJ; Rahman K; Bushell AJ; Mills CO; Elias E; Billington D
Biochim Biophys Acta; 1995 Jun; 1256(3):374-80. PubMed ID: 7786902
[TBL] [Abstract][Full Text] [Related]
17. Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats.
Lorenzo-Zúñiga V; Bartolí R; Planas R; Hofmann AF; Viñado B; Hagey LR; Hernández JM; Mañé J; Alvarez MA; Ausina V; Gassull MA
Hepatology; 2003 Mar; 37(3):551-7. PubMed ID: 12601352
[TBL] [Abstract][Full Text] [Related]
18. Microtubule-dependent transport of bile salts through hepatocytes: cholic vs. taurocholatic acid.
Hofmann AF
Hepatology; 1994 Nov; 20(5):1375-8. PubMed ID: 7927277
[No Abstract] [Full Text] [Related]
19. Secretin activation of the apical Na+-dependent bile acid transporter is associated with cholehepatic shunting in rats.
Alpini G; Glaser S; Baiocchi L; Francis H; Xia X; Lesage G
Hepatology; 2005 May; 41(5):1037-45. PubMed ID: 15834929
[TBL] [Abstract][Full Text] [Related]
20. Chemical synthesis of bile acid acyl-adenylates and formation by a rat liver microsomal fraction.
Ikegawa S; Ito H; Ohshima M; Maeda M; Hofmann AF; Mitamura K
Steroids; 2009 Sep; 74(9):751-7. PubMed ID: 19376146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
